CNS Radiotherapy As Bridging Prior to CAR T-Cell Therapy for Non-Hodgkin B-Cell Lymphoma

被引：0
|
作者：
Cederquist, Gustav [1 ]
Schefflein, Javin [2 ]
Devlin, Sean M. [3 ]
Hubbeling, Harper [1 ]
Tringale, Kathryn [1 ]
Shah, Gunjan L. [4 ]
Tomas, Ana Alarcon [4 ]
Shouval, Roni [5 ]
Hajj, Carla [1 ]
Fregonese, Beatrice [1 ]
Dahi, Parastoo B. [5 ]
Lin, Richard J. [5 ]
Palomba, Maria Lia [6 ]
Perales, Miguel-Angel [5 ]
Salles, Gilles [6 ]
Falchi, Lorenzo [6 ]
Grommes, Christian [7 ]
Scordo, Michael [5 ]
Yahalom, Joachim [1 ]
Imber, Brandon S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc, Dept Neurol, New York, NY USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-190326
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Longitudinal analysis of CAR T-cell and immune cell populations in patients with aggressive B-cell non-Hodgkin Lymphoma: T-cell phenotypes predict the outcomes after CAR T-cell therapy
    Chitadze, G.
    Stuebig, T.
    Laqua, A.
    Nakov, P.
    Kehden, B.
    Khouja, M.
    Versteegen, T.
    Schroeder, T.
    Martens, T.
    Lohneis, A.
    Iaccarino, I.
    Klapper, W.
    Peipp, M.
    Klausz, K.
    Ritgen, M.
    Adam, S.
    Schuster, S. O.
    Fransecky, L.
    Valerius, T.
    Schub, N.
    Stoelzel, F.
    Brueggemann, M.
    Baldus, C. D.
    Pott, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 74 - 74
  • [22] CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas
    Cederquist, Gustav Y.
    Schefflein, Javin
    Devlin, Sean M.
    Shah, Gunjan L.
    Shouval, Roni
    Hubbeling, Harper
    Tringale, Kathryn
    Tomas, Ana Alarcon
    Fregonese, Beatrice
    Hajj, Carla
    Boardman, Alexander
    De Abia, Alejandro Luna
    Corona, Magdalena
    Cassanello, Giulio
    Dahi, Parastoo B.
    Lin, Richard J.
    Ghione, Paola
    Salles, Gilles
    Perales, Miguel-Angel
    Palomba, M. Lia
    Falchi, Lorenzo
    Scordo, Michael
    Grommes, Christian
    Yahalom, Joachim
    Imber, Brandon S.
    BLOOD ADVANCES, 2024, 8 (19) : 5192 - 5199
  • [23] Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma
    Saifi, Omran
    Breen, William G.
    Lester, Scott C.
    Rule, William G.
    Stish, Bradley
    Rosenthal, Allison
    Munoz, Javier
    Herchko, Steven M.
    Murthy, Hemant S.
    Lin, Yi
    Bansal, Radhika
    Hathcock, Matthew A.
    Bennani, N. Nora
    Paludo, Jonas
    Wang, Yucai
    Khurana, Arushi
    Bisneto, Jose C. Villasboas
    Johnston, Patrick B.
    Ansell, Stephen M.
    Iqbal, Madiha
    Tun, Han
    Ayala, Ernesto
    Kharfan-Dabaja, Mohamed A.
    Hoppe, Bradford S.
    Peterson, Jennifer L.
    RADIOTHERAPY AND ONCOLOGY, 2022, 166 : 171 - 179
  • [24] Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
    Ababneh, Hazim S.
    Ng, Andrea K.
    Frigault, Matthew J.
    Jacobson, Caron A.
    Patel, Chirayu G.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (09) : 1837 - 1840
  • [25] Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy
    Ababneh, Hazim
    Ng, Andrea
    Frigaul, Matthew
    Jacobson, Caron
    Patel, Chirayu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (10): : S26 - S26
  • [26] Derangement of the T-cell repertoire in patients with B-cell non-Hodgkin's lymphoma
    Fozza, Claudio
    Corda, Giovanna
    Virdis, Patrizia
    Contini, Salvatore
    Barraqueddu, Francesca
    Galleu, Antonio
    Isoni, Antonella
    Cossu, Antonella
    Dore, Fausto
    Careddu, Maria G.
    Bonfigli, Silvana
    Giannico, Barbara
    Longinotti, Maurizio
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (04) : 298 - 309
  • [27] CAR T-Cell Therapy in Large B-Cell Lymphoma
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (11): : 1065 - 1065
  • [28] T-cell non-Hodgkin lymphoma
    Rizvi, MA
    Evens, AM
    Tallman, MS
    Nelson, BP
    Rosen, ST
    BLOOD, 2006, 107 (04) : 1255 - 1264
  • [29] CENTRAL NERVOUS SYSTEM BRIDGING RADIOTHERAPY (CNS-BRT) ACHIEVES RAPID CYTOREDUCTION PRIOR TO CAR T-CELL THERAPY FOR AGGRESSIVE B-CELL LYMPHOMAS
    Cederquist, Gustav
    Schefflein, Javin
    Devlin, Sean
    Shah, Gunjan
    Shouval, Roni
    Hubbeling, Harper
    Tringale, Kathryn
    Fregonese, Beatrice
    Hajj, Carla
    Boardman, Alexander
    Dahi, Parastoo
    Lin, Richard
    Ghione, Paola
    Salles, Gilles
    Perales, Miguel-Angel
    Palomba, M. Lia
    Falchi, Lorenzo
    Scordo, Michael
    Grommes, Christian
    Yahalom, Joachim
    Imber, Brandon
    NEURO-ONCOLOGY, 2024, 26
  • [30] Chimeric Antigen Receptor T-Cell Therapy for Companion Canines with Spontaneous B-Cell Non-Hodgkin Lymphoma
    O'Connor, Colleen M.
    Olivares, Simon
    Ang, Sonny
    Champlin, Richard E.
    Wilson-Robles, Heather M.
    Cooper, Laurence J. N.
    MOLECULAR THERAPY, 2013, 21 : S249 - S249
12345